Kerr Douglas 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Kerr Douglas（CIK 1814189）在 1 家公司共报告 11 笔 SEC Form 4 内部人交易（最近一笔 2026-09-08）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-08 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | 卖出 | 3,745 | $91,191 |
| 2026-09-08 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | 卖出 | 1,290 | $24,355 |
| 2026-08-17 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | 卖出 | 1,556 | $40,892 |
| 2026-06-17 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | 卖出 | 887 | $16,259 |
| 2026-05-14 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | 卖出 | 1,564 | $28,715 |
| 2026-03-06 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | 卖出 | 904 | $13,470 |
| 2026-02-17 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | 买入 | 85,000 | $0 |
| 2025-12-05 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | 卖出 | 880 | $18,234 |
| 2025-09-08 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | 卖出 | 3,552 | $47,135 |
| 2025-09-08 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | 卖出 | 873 | $11,707 |
| 2025-06-06 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | 卖出 | 1,342 | $17,916 |
来源：SEC Form 4 申报文件 · 截至 2026-09-08